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1. Introduction  
Subacute Scerosing Pan Encephalitis (SSPE), a devastating brain disease of young children 
was frequently taken into account in the differential diagnosis of the so-called 
"neurodegenerative diseases of childhood" by paediatricians, child neurologist and 
psychiatrists during the second half of the last century. Fortunately, this diagnosis is 
considered very rarely today in well developed countries, mainly in the western 
hemisphere. This does not mean that the disease "vanished" although its incidence 
dramatically declined.  
One of the reasons to include SSPE in a book dedicated to "encephalitis " is not only for 
historical purposes, but also to remind the young generation of physicians dealing with 
neuro-psychiatric disorders of children and young adults, that SSPE still exists. 
Another goal of this chapter is to point out the reasons why SSPE is one of several disorders 
which fulfil the concept of  "slow virus infection", a term brought up  by Bjorn Sigurdsson in 
1954, after he and his co-workers discovered that three sheep diseases, scrapie, visna, and 
sheep pulmonary adenomathosis  are all caused by the same retrovirus. This revolutionary 
concept was later utilized by D. Carleton Gajdusek to study "infections of unknown origin" 
such as Kuru and Creuzfeldt-Jacob disease. The new generation of paediatricians and child 
neurologists who most probably have never seen a case of SSPE, will quite naturally skip the 
paragraph in the text-book which is dedicated to this disease. For those young colleagues 
this chapter may be more than "interesting" or "informative". It is written for them and 
hopefully may help them to diagnose correctly their first case and offer the present available 
palliative drug treatment. Regarding the readers in the field of public health, it may enhance 
their drive to achieve widespread and complete coverage of measles immunization of 
populations at risk. 
2. History 
The suggestion that SSPE may be a viral infection was raised by Dawson who published 2 
consecutive papers in 1933 and 1934 in which he described  2 children from Tennessee who 
died after a progressive course characterized by involuntary jerking of the limbs and mental 
deterioration. In their brains he noted encephalitic changes with intracellular eosinophilic 
inclusion bodies in numerous cortical neurons which reminded him of viral inclusions. 
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(Dawson, 1933; 1934). In 1939, an additional case was described in Germany. This was a 17 
year old boy who died after 2 years of progressive neurological deterioration.In his brain 
nodular changes in the white and gray matter resembling "encephalomyelitis with 
characteristics of Japanese Encephalitis", were observed. (Pette & Döring, 1939, Case 3). In 
1945, Van Bogaert described a clinically similar case in whom the dominant 
neuropathological features consisted of demyelination and glial proliferation in the white 
matter which were summarized by him as “subacute sclerosing leukoencephalitis” (Van 
Bogaert, 1945). Thus, at this stage, 4 children with similar clinical features of progressive 
fatal neuro- behavioural deterioration and "jerks", have been described. However, in their 
brains variable and non uniform pathological findings including inflammatory changes, 
intraneuronal inclusion bodies, nodular "sclerotic" changes both in the white and gray 
matter were reported and demyelination with glial proliferation in the white matter.  
During the next few years children with diverse clinical features resembling progressive 
encephalitis have been described. However, only in 1957, Poser and Radermecker reached 
the conclusion that all those patients suffer from a similar disorder which they called 
Subacute Sclerosing Leucoencephalitis. (Poser & Radermecker, 1957). They based their 
conclusion on a study of 7 cases including 3 post- mortem examinations. Finally, the term 
SSPE was coined by Greenfield in 1950 (Greenfield, 1950). Boutellie should be credited for 
his significant contribution to the understanding of the true nature of SSPE. With the aid of 
the electron- microscope he identified structures which resembled nucleocapsids of 
paramyxovirus in SSPE (Boutellie et al., 1965). This finding was soon followed by a search 
for antibodies to paramyxovirus in the blood and CSF of patients with SSPE which yielded 
very high titers of anti- measles antibodies in the blood and CSF of all patients studied 
(Connolly et al., 1967). These pivotal findings led to the crucial conclusion that SSPE is 
related to infection with measles virus (MV). Later, the mechanisms by which this virus is 
able to persists in nerve cells for long periods of time in a dormant form were elucidated 
and shed light on the processes involved in "slow virus infection". The conclusion reached 
by epidemiological observations that there is a relation between early measles infection and 
SSPE led to a world-wide measles immunization program followed by a dramatic  decline in 
the incidence of SSPE, up to the present situation where in most of the western developed 
countries, SSPE was almost completely eradicated. 
3. The clinical spectrum of SSPE 
There are 2 forms of encephalitis following measles infection. The first is the relatively 
common acute post infections measles encephalitis which develops in about 0.1 percent of 
immunocompetent patients and carries a 20 percent mortality rate. This form of encephalitis 
is not caused by direct invasion of the brain by MV. Indeed, only with highly sensitive 
methods could MV specific nucleic acids be detected in the brains of patients with this form 
of encephalitis. Those findings are in line with the assumption that this is a true example of 
measles virus induced pathological immune mediated "post-infectious" encephalitis. In 
contras, MV is present in the brains of the immunocompetent patients and causes SSPE 
while in immunocompromized patients it causes Measles Inclusion Body Encephalitis. Both 
conditions are fatal and present clinically months or years after the initial measles infection. 
The clinical presentation of SSPE is often insidious and frequently attributed to 
psychological or behavioural problems. The exception to this are those cases who present 
acutely with focal neurological signs and progress rapidly to coma and death.  
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The following case report is a classical example of the fulminant form of SSPE which affects 
about 10% of all patients (PeBenito et al., 1997). 
3.1 Case report 1 
This 7 year old, previously healthy boy was born in 1970 to healthy unrelated parents of 
Jewish –Yemenite origin. He was brought to the emergency room (ER), at the Beilinson 
Medical Center in the state of semi- coma.Past medical and family history were non-
contributory. He was well until 2 days prior to admission when mild fever was followed by 
complains of right sided difficulties in using his hand and leg. He was previously seen by a 
local physician who diagnosed " common cold ". In the ER his Glasgow Coma Scale Score  
was 6/15 (eye opening 1, best verbal response 1, best motor response 4). The abnormal 
neurological findings were lack of withdrawal from deep pain with brisk DTR's and 
extensor plantar response on the right side. There were no involuntary movements. 
Immediate brain CT followed by 4 vessel cerebral angiography were normal. An EEG 
disclosed rhythmic periodic delta generalized discharges with flat electrical background. A 
lumbar puncture disclosed normal opening pressure, crystal clear sterile CSF with slightly 
increased  protein, normal glucose and negative Gram stain. Serum measles antibody titer 
by complement fixation was 1:256 and that of the CSF 1:16. There were no clinical  signs of 
measles. The boy died on the 3rd hospital day and the autopsy confirmed the clinical 
diagnosis of SSPE. He had measles at the age of 2 years  and did not receive measles  
vaccination.  
The following case report represents the protracted and peculiar clinical course of SSPE  
3.2 Case report 2 
This 16 year old girl was born in 1963 to healthy Jewish parents who immigrated to Israel 
from Morocco in 1949. Her past medical and developmental history was unremarkable. 
There was no history of clinical measles or an exanthematous early febrile illness. She 
received measles immunization soon after it was initiated in Israel during 1967. At the age of 
7 years, during the second elementary school year, an unexplained decline in her school 
performance was noted. A paediatric neurological assessment was summarized as Attention 
Deficit Disorder for which supplementary teaching and Methylphenidate (RitalinR) 10 mg 
daily was prescribed. An EEG showed right sides periodic delta wave discharges and for 
that brain CT with contract enhancement was done and read normal. The EEG findings 
were attributed to "sweating artefact".The clinical course was stable for 18 months during 
which a slow deterioration was noticed in her general alertness and vigilance according to 
the mother. This was however denied by her school teachers who thought that she did quite 
well in school and received excellent school reports. The anxious mother consulted several 
child neurologists and psychiatrists who failed to find any abnormalities. A repeated EEG 
showed generalized periodic slow delta bursts with slow background activity. Serum and 
CSF measles antibody titers by complement fixation were 1: 256 and 1:32 respectively. A 
diagnosis of SSPE was considered for which daily Isoprinosine and several courses of 
intravenous "Thymic Humoral Factor" (THF), were given as part of 2 experimental 
treatment trials which were at that time done in Israel. That was followed by clinical 
improvement in her vigilance. She enjoyed the routine daily life of a young girl until the age 
of 11 years when frequent falls, schoolwork deterioration and sudden brief neck and back 
flexion movements associated with the falls were noted. She started to behave "strangely", 
www.intechopen.com
 
Pathogenesis of Encephalitis 
 
138 
and had difficulties in recognition of familiar faces and objects. When examined by me for 
the first time she had marked visual agnosia and neck and axial myoclonus. Her EEG 
showed additional background slowing with "metronomic" delta bursts resembling "Burst 
Suppression" pattern. Clonazepam (clonexR) was helpful only for a short period of time. 
Both serum and CSF measles antibody titers, and brain CT were almost unchanged. 
Her condition gradually deteriorated. She spent her last 2 years of life in a nursing home 
during which continuous very high fever unresponsive to a variety of antipyretics, bouts of 
sweating accompanied by  brady-tachy arrhythmia, and generalized rigidity were present. 
Her EEG was almost isoelectirc without evidence of periodic bursts during the last weeks of 
her life. She died of aspiration pneumonia. Autopsy was not permitted for religious reasons. 
Those 2 cases represent the wide spectrum of the clinical features and course of SSPE and 
also the difficulties of considering SSPE in the differential diagnosis at the early stags of the 
disease, a fact which explains the delay in the diagnosis in some cases.  
The classical clinical diagnostic features of SSPE are shown in Table 1, and the clinical 
staging of the disease is shown in table 2. 
                                    
Childhood onset of mental and behavioral regression with : 
 Myoclonic Jerks  
 EEG- Generalized bilateral rhythmic synchronous bursts of spike-wave or slow wave 
complexes   
 Elevated measles antibody titers in serum and CSF without concomitant evidence of 
clinical measles  
 Elevated CSF IgG, presence of oligoclonal IgG bands 
In the brain, presence of perivascular inflammatory cuffing, cortical and subcortical  
white matter astro-microgliosis, neurophagia and Cowdry type A, eosinophilic  
intaranuclear  inclusion bodies 
Table 1. SSPE - Clinical and laboratory diagnostic criteria 
 
i. Personality changes accompanied by school failure and bizarre behavior 
ii. Axial (Especially characteristic rapid  neck flexion) massive myoclonus causing  
frequent and violent falls  
iii. Generalized rigidity with extarapyramidal features and progressive 
unresponsiveness  
iv. Minimal conscious state progressing to akinetic mutism with severe progressive 
autonomic failure 
Table 2. Clinical staging of SSPE  
4. Characteristic clinical features 
The majority of the patients the initial symptoms are noted between the ages of 8-11 years, 
about 6-7 years after measles infection. Zilber et al. initiated a country survey of SSPE in 
Israel by obtaining information from the Israeli National Neurological Diseases Register 
(INNDR), the Central Virus Laboratory which at that time tested sera and CSF for measles 
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antibodies throughout the country and the medical records of patients diagnosed with SSPE 
from all hospitals in the country between the years 1960-1973 (Zilebr at al., 1983). Hundred 
and eight such patients were detected, 40 of them were followed by the author of this 
chapter. The onset of SSPE accrued during 1968-1979. The mean age of onset was almost 
identical to that reported for children in USA (9.5 y.) and UK (9.8 y.). The interval (in years) 
between clinical measles and onset of SSPE in the Israeli children (7.4 y.), was also similar to 
that of USA and UK children (7.0 and 6.8 y. respectively). However, the interval (in years) 
between the time of measles vaccination and SSPE varied between 6.5 years in Israel, and 3.3 
and 3.0 in the USA and UK respectively.  
All Israeli children with SSPE had progressive neurobehavioral deterioration, myoclonic 
jerks and characteristic EEG. Sixty eight percent had elevated serum measles antibodies and 
89% had increased titer of those antibodies in the CSF. A quite surprising finding was the 
low percentage of patients (13%) with brain pathology characteristic of SSPE.  
True epileptic seizures were a rarity. We have seen only 6 out of our cohort of 40 patients 
who had true epileptic seizures. Those were 5 boys and 1 girl who had a similar age of onset 
and disease features. The mean interval between SSPE onset and the first seizure was 15 
months (3 – 24). The EEG was mostly focal and the response to Anti Convulsive Drugs 
(ACD) varied from excellent in 2 patients, good in one and poor in 2. One patient who failed 
to respond to ACD was given a ketogenic diet which was beneficial. The common 
denominator of these patients was antecedent neurological impairment. Four suffered from 
viral encephalitis at one year of age, one had severe learning problems diagnosed prior to 
the onset of SSPE and the sixth had severe congenital sensory-neural deafness. Two similar 
cases have been recently reported (Demir et al., 2009). In few patients focal seizures in the 
form of epilepsia partialis continua and an EEG showing Periodic Lateralizing Epileptic 
Discharges (PLED) were reported. This pattern was associated with a fulminant course 
(Santoshkumar & Radhakrishnan 1996, Cherian et al., 2009). As mentioned above, earlier 
publications indicated that epileptic seizures are rare and appear at late stages of the 
disease. More recent publications such as the paper by Kissani (Kissani et al., 2001), indicate 
that epilepsy is rather frequent. In a series of 70 patients with SSPE from Morocco, 30 had  
 
 
Fig. 1. Patients with SSPE and partial seizures. Note the slow background activity, 
continuous fronto-central delta activity, periodic non-rhytmic delta bursts and left anterior 
temporal spikes. 
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true epileptic seizures.In two-thirds of them the seizures started during the first year of the 
disease and in 23%, were the presenting symptom. Partial seizures with secondary 
generalization were most common in the very early stages of the disease and frequently led 
to the correct diagnosis. When seizures appeared late in the course of the disease (43%), they 
were mainly generalized tonic-clonic (GTCS). The "heralding" partial seizures are most 
probably indicators of focal onset of encephalitis with generalized spread later on.  
The diagnosis of SSPE is quite straight forward and easily reached in children if the 
attending paediatricians and child neurologists are familiar with the disease. This is quite 
different when the disease affects adults. The occurrence of SSPE in subjects older than 18 
years is quite rare, comprising 1-12.7% of all patients (Prashanth et al., 2006). Adult onset 
SSPE presents at an average age of 25 years and rarely follows the classical clinical stages 
mentioned above. Visual symptoms at presentation are frequent (Singer et al., 1997), while 
myoclonus may be absent. About 30 % of 52 such patients lacked a history of measles 
(Fabian et al., 2010).  
5. Electroencephalographic and neuroimaging features 
The most characteristic EEG feature is the periodic, stereotyped, high voltage discharges 
which appear concomitantly with the appearance of the myoclonic jerks. At early stages of 
the disease, the EEG may be normal or show moderate non-specific generalized slowing. As 
the diseases progresses, the periodic discharge pattern emerges, at first only during sleep, 
before myoclonic jerks are evident. In early stages, administration of IV diazepam can bring 
out the typical bursts. Somewhat later in the course and concomitantly with the appearance 
of typical myoclonus, the characteristic periodic discharge pattern can be seen also during 
wakefulness. This pattern consists of bilateral synchronous symmetrical bursts with an 
amplitude of 200-500 mV. Each burst consists of polyphasic, monomorphic delta waves. The 
bursts appear every 4-10 seconds with an identical morphology in any recording lead and 
are rhythmic ("metronomic"). The bursts are "time locked" with the myoclonic jerks. The 
interval between the bursts becomes shorter with disease progression. In advanced stages 
this pattern is replaced by disorganized slow delta rhythm. The voltage of the recording gets 
smaller and at stage IV it may became almost iso- electric (Figure.2) 
In a relatively recent study from India (Praveen-Kumar et al., 2007), the EEG features of 58 
patients with SSPE (stage I: 10.2%; II: 64%; III: 25.8%), were analyzed and related to the stage 
of disease and neuroimaging findings. Bursts as defined above were found in 98% of the 
patients. Those were periodic in 55%, "quasi-periodic" in 36% and non-periodic in 6%. The 
periodic bursts were asymmetrical in 33%. The burst morphology, frequency and inter-burst 
interval were not influenced by hyperventilation, photic or sensory stimulation. Normal 
background was recorded in all patients in stage I, and slow background in all other stages. 
Spike and sharp wave epileptiform discharges were present in 72.4% of the patients. Those 
were mostly generalized and only in 10 patients epileptiform activity was lateralized or 
multifocal. The focal discharges were mostly fronto-parietal. Periodic Lateralizing Epileptic 
Discharges (PLED's), were present in 10 recordings. Asymmetry of background activity or 
bursts were associated with lateralizing neurological deficits. However, there was no 
correlation between the EEG asymmetry and CT or MRI findings. Brain neuroimaging was 
performed in 44 patients and both CT and MRI in 11 patients only. The main neuro-imaging 
findings consisted of brain oedema and atrophy seen in all stages of the disease while signal 
intensity changes were present in stages II-III. Parieto-occipital white matter was affected in 
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Fig. 2. EEG in various stages of SSPE. A: The background activity is disorganized with few 
repetitive high voltage delta bursts with fronto-central amplitude accentuation in the early 
stages of the disease. B: Typical "metronomic" delta burst pattern with almost flat amplitude 
during burst intervals recorded during the advanced stages of SSPE C: A uniform pattern of 
monomorphic slow waves at a very advanced stage of SSPE.  
stage II while diffuse fronto-parteital changes were more common in stage II-III. There was 
no contrast enhancement by Iodine or Gadolinium. Although there was no correlation 
between the imaging features and focal EEG changes or the abnormal neurological findings, 
a significant association between visual deficits and parieto-occipital signal changes on MRI 
was found. In a more recent study (Aydin et al., 2009), 17 patients with SSPE who had a 
routine normal MRI and 30 healthy matched controls underwent T1-weighted 
magnetization-prepared rapid acquisition gradient echo images. When optimized method of 
voxel-based morphometry performed across-sectional analysis were applied to search for 
gray matter volume differences between the patients and controls, a fronto-temporal 
reduction of the cortical gray matter was found in the patients,regardless of  the duration of 
symptoms or the presence and nature of  neurological deficits. 
6. Neuropathology 
In the early phase of the disease brain oedema with DNA and RNA oxidative damage 
within infected cells are the typical findings. There is evidence of lipid peroxidation in areas 
of early demyelination (Hayashi et al., 2002). The main histopathological findings in the 
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acute phase are inflammatory and consist of the classical cortical and subcortical 
"perivascular cuffing", spongiosis and demyelination, sparing the cerebellum (Figure 3).  
 
 
Fig. 3. Postmortem brain microscopy of SSPE. (a). Typical lymphocytic perivascular  cuffing 
within brain parenchyma (H&E, X100 ) (b). Cortical neurons with the characteristic 
intranuclear eosinophilic Cowdry type-A inclusions surrounded by a clear hallo (H&E 
X400). (c). Profound astrocytic proliferation (PAS X190). (d). Elecromicrograph of an 
inclusion body showing curvilinear structures which are most probably viral nucleocapsids 
(X 20000).   
Initially, posterior brain regions are the most affected. Pronounced changes are seen in the 
medial thalamus and the deep structures. With disease progression more anterior areas, 
brain stem and spinal cord are also affected. The inflammatory cellular response consists of 
focal and/or diffuse perivascular infiltrates of lymphocytes, plasma cells and phagocytes 
which are present within brain parenchyma as well as in the menings. The astrocytes, 
oligodendrocytes and microvascular endothelium are the mostly infected cell types (Allen et 
al., 1996).The nuclear and cytoplasmic inclusion bodies seen in neurons and 
oligodendrocytes are Cowdry type-A inclusions which contain homogeneous eosinophilic 
material. They are diffusely distributed mostly in the fulminant cases while the small 
multiple Cowdry type-B inclusion bodies, are almost always present in the brainstem. The 
nuclear inclusions correspond to measles viral particles and contain viral antigens. 
Neurofibrillary tangles may be present within neurons and oligodendrocytes. The tangles 
contain viral genome as shown by in-situ hybridization. Those findings suggest that the 
tangles are the result of the viral infection. (McQuaid et al., 1994). The inflammatory reaction 
and even the inclusion bodies are typical for the early stages of the disease and are hard to 
find at the later stages. Typically for SSPE as a model for slow virus infection, it is very 
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difficult to isolate even a small amount of infectious virus from the brain while viral 
antigens can be quite easily identified. 
7. Immunopathology 
A large number of major histocompatibility complex (MHC) class I-II positive cells were 
seen by immunohistochemical methods in SSPE brains, especially in a perivascular 
distribution. By morphological criteria, HLA –DR positive microglia and reactive astrocytes 
were also identified. (Hofman et al., 1991). Although cell mediated immunity was found to 
be abnormal in a small series of patients such as our own where 11/15 patients had some 
evidence of such an impairment (Handzel et al.,1983), no specific immune defect was found 
in  SSPE (Schneider–Schaulies et al., 2003). The inflammatory perivascular cell infiltrates are 
predominantly CD4+ T cells, while B cells are seen more frequently in parenchymal 
inflammatory infiltrates. We have shown in 11 patients with SSPE, that similar to matched 
controls, they had no detectable plasma interferon (INF) activity. However, their PBMC 
failed to produce INF following stimulation with polyinosinic:polycytidilic acid (poly I:C 
and Phytohemagglutinin (PHA) (Gadoth et al., 1989)   
8. Pathophysiology 
One of the prevailing theories suggests that in spite of the lack of evidence for a specific 
immune defect causing SSPE, impaired immune response plays an important role in its 
pathophysiology. The observation that early infection with MV virus at the time when the 
immune system is relatively immature, is associated with increased risk for SSPE (Tuxhorn, 
2004), was a pivotal step  in understanding the disease. Normally, during the incubation 
phase of measles, the invading virus induces a cell mediated immune response with 
activation of T-Helper 1 (Th1) lymphocytes, release of INF- α, and interleukin 2 (IL-2), which 
is capable of eradicating the invading virus particles from the infected cells. Following the 
characteristic measles papulo-macular skin rash, a humoral antibody mediated long term 
immunity against future infection is established via the production of Th2 lymphocytes, 
release of mainly IL- 4 and to a lesser extent INF-α and IL-2. (Griffin et al., 1994). Due to 
genetic polymorphism, patients with SSPE have an inadequate cellular immune responses 
to common antigens and produce markedly decreased amounts of IFN (Handzel et al., 
1983), and IL – 2,10,12, while producing increased amounts of IL -4 and IL-1b. (Yentür et al., 
2005). The induction of this set of humoral immune responses in patients with SSPE rather 
than producing a cellular immune response which is capable of completely eradicate the 
MV from the infected cells, is believed to play a major role in the pathogenesis of the disease 
and contributes to the ability of the mutated measles virus to persist in a dormant form 
within the brain. (Inoue et al., 2002).  
The variable incidence rates of SSPE in different populations and ethnic groups can be 
partially attributed to genetic polymorphism in addition to a number of epidemiological 
variables which will be discussed below. 
Measles virus uses the cluster of differentiation (CD) protein 46 and fusion protein (protein 
F), to invade the neuron. The fact that high antibody titers to CD9 were detected in CSF of 
patients with SSPE who had severe brain atrophy, indicates that this protein plays also a 
role in neuronal invasion of the virus (Shimizu et al., 2002). After entering the cell the viral 
www.intechopen.com
 
Pathogenesis of Encephalitis 
 
144 
matrix protein undergoes mutations and cannot be recognized by the immune system. This 
is followed by virus replication and persistence within the infected cell without being 
eradicated by the immune system (Makhortova et al., 2007). In addition, a truncated protein 
F receptor may also play a causative role. Neurokinin-1 is implicated in the spread of the 
mutated virus to adjacent cells. After a variable period when the virus is dormant, it induces 
an inflammatory immune mediated reaction directed against the infected cells, which 
results in widespread CNS damage. Those mentioned immune mechanisms may also play a 
role in other chronic demyelinating CNS disorders.  
9. Treatment 
SPEE is always fatal. A relative beneficial effect was achieved with either daily oral 
Isoprinosine or in combination with weekly intrathecal INF –α. Although this combination 
is considered the most beneficial, approximately 22% of the treated patients suffered from 
complications related to the intrathecal reservoir. Isoprinosine (InosiplexR), is a derivative of 
Inosine and p-acetamidobenzoic acid salt of N,N-dimethylamydo-2- propanol. This drug is 
considered as an immunomodulator agent capable of impairing viral replication. It is quite 
safe when given for extended periods of time. The positive immunomodulation effect of 
Isoprinosine was demonstrated by an experiment during which PBMC of patients with 
SSPE failed to produce INF after stimulation with poly I:C and PHA. The patients were then 
given oral Isoprinosine for several days which resulted in significant elevation of serum INF 
and corrected the failure of INF production by the similarly stimulated PBMC. Moreover, 10 
days after discontinuation of the drug, the INF system returned to its inactive state. Several 
patients were treated for extended periods of time with a 20% remission rate and or 4 year 
survival. (Gadoth et al., 1989). Other investigators have shown a beneficial effect of the drug 
in up to 30-35% of the patients which is significantly higher than the reported 5% 
spontaneous remission rate (Dyken et al., 1982). 
Other agents such as Ribavirin, which blocks RNA polymerase without and in combination 
with INF, Anti CD2O antibodies, THF, Amantadine, Steroids and plasmapehresis showed 
some beneficial effect in selected non-randomized trials. 
Several patients have been treated with intraventricular INF-α alone or in combination with 
oral Isoprinosine but with no advantage over the intrathecal route (Yalaz et al., 1992). 
10. Epidemiology 
The dramatic changes in the epidemiology of SSPE in relation to the world-wide 
immunization project against measles are fascinating. The reduction in measles incidence 
especially in immunized infants was followed by a dramatic fall in the rate of SSPE in the 
developed countries of the western hemisphere and in other world regions where measles 
immunization became mandatory. In addition, some changes occurred in the previously 
described "classical" characteristics of the disease such as the age of onset and a number of 
clinical features. In a relatively recent world wide review of the rate of measles and SSPE 
before and after the institution of measles immunization, the dramatic drop in the incidence 
of SSPE due to immunization was clearly shown (Campbell et al., 2007).  
Israel served and still serves as a good site for classical epidemiological studies because of 
its heterogenic ethnic population, high standard of medical care and a well organized 
medical and health system which enables the particular researcher to obtain well 
www.intechopen.com
 
Subacute Sclerosing Pan-Encephalitis (SSPE) – Past and Present 
 
145 
documented data throughout the country. For this reason data from Israel can provide an 
excellent example of the role of mass measles immunization on the rate of SSPE. The 
country has a wide-spread network of Mother and Child health clinics which serve the 
entire county's population. The individual clinics keep careful records of each child's 
immunization program, and the medical staff is alert to those who fail to show for their 
clinic visits or to the immunization schedule, established by the Israeli Ministry of health. 
Due to the nominal cost of those services, it can be assumed that the diagnosis and reports of 
patients with SSPE are accurate and most probably complete. Population studies of SSPE 
were carried out in Israel since 1960, while mass measles vaccination was introduced in 
1967. Thus, most of the children born after February 1965 were immunized. Considering the 
standard of medical care in Israel and the size of its population in 1975 (3.5 million), it can be 
assumed that a rare disease such as SSPE was reported in sufficient numbers during those 
years when the local and world wide SSPE "epidemic" suddenly emerged. All those factors 
enabled an accurate analysis of SSPE incidence in regard to a number of variables including 
the role of mass immunization against measles. Zilber (Zilber et al., 1983), obtained data on 
SSPE rates from the Israeli National Neurological Disease Register which received 
notification on all neurological disorders recorded in all hospitalized patients around the 
country. Death certifications with a code for any neurological disorder were also retrieved. 
Assuming that the varied and dramatic symptoms of SSPE will eventually lead to 
hospitalization of the affected child, it is highly likely that the register was notified of almost 
all patients with SSPE during the period of this study which covered the period of 1968-
1979. The medical records of all detected cases were obtained. As the register was notified 
also on cases of measles encephalitis, non-specific encephalitis, and degenerative 
progressive neurological diseases in children, the charts of such cases were also obtained 
and reviewed for possible SSPE. The records from the central virology laboratory which 
performed serum and CSF measles antibody titers for the entire country since 1968 until 
the publication of the mentioned study were searched for tests with increased measles 
antibody titers and the patients details and medical records were obtained. In a previous 
study by the same group (Soffer et al., 1975) the medical records of patients with the 
diagnosis of SSPE from all Israeli hospitals for the period of 1960-1973 were reviewed. In 
addition, the departments of paediatrics, neurology and the EEG laboratories across the 
country were asked to provide information on additional patients. The multi-source 
information thus gathered enabled to exclude multiple reports of the same patient and 
provided a high level of ascertainment of the data obtained. The main findings of this 
study confirmed the presence of a steep drop in incidence of SSPE in vaccinated Israeli 
children noted mainly in 1977, 10 years after the initiation of mass immunization. The rate 
of SSPE remained low at the completion of this study in 1979. The calculated rate of SSPE 
(per 106 live births) during the period of 1965-1971 was 246 in non vaccinated patients 
compared to 27 in vaccinated subjects. The rate of 27 included patients who developed 
measles after immunization. When those patients were excluded the rate dropped to 17. 
The relation between the rate of measles infection and SSPE in Israel is shown in Figure 4. 
The rates of SSPE for Israeli Jews and Arabs were compared to rates for Arabs living in 
Gaza and the west bank where measles immunization was not compulsory but available. 
The rates dropped steeply for both Israeli Jews and Arabs in 1977 with a significant delay 
in Gaza and the west bank. However, even in this particular population the decline in the 
number of new cases was dramatic to the point that no new cases were reported in both 
populations after 1986 (Figure 5). 
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Fig. 4. The incidence of SSPE in relation to the rate of measles infection in Israel during the 
epidemic years of SSPE. 
Similar to data from other countries, the age of onset in Israeli patients increased parallel to 
the decrease in the rate of measles and SSPE, although in Arabs it remained around 10 years 
of age. (Figure 6). 
While new cases are a rarity today in counties with good measles control such as USA 
where the rate is very low (0.01/106), it is still quite high in counties with poor measles 
control (India; 21/106, Japan; 11/106, and Turkey; 0.461/106,(Gutierrez et al., 2010). One of 
the highest rates of SSPE was found and is still present in Papua- New Guinea (PNG). This 
rate is only partially related to poor immunization control. During the years 1988-1999, a 
rate of 13-98/106 was found in individuals younger than 20 years of age. The rate of measles 
immunization in this particular population was stable at a level between 50-60 % of the 
population at risk during 1997-2008. A recent study from the referral hospital of the Madang 
Province in PNG mentioned a rate of 54/106 in individuals younger than 20 years, during 
2007–2009. The rate was much higher in 4 sub-districts with an annual incidence of  
> 100/106 among the same age group. Those rates are the highest ever reported. The 
patients in this study contracted measles during their first year of life in 2002 and presented 
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with SSPE 6-7 years later. A possible explanation for that very high rate in spite of a 60% 
rate of measles immunization in this region is the observation that only 36% of young 
Melanesian children respond well to measles vaccine and develop immunity to 
measles.(Manning et al., 2011). 
From the above mentioned epidemiological data it is evident that SSPE is a "vanishing" 
disease in well developed countries while the disease is still taking the life of children in 
underdeveloped world regions. The variable incidence of SSPE can be explained not only in 
relation to the variability in measles morbidity, the degree of immunization coverage, the 
age of immunization, the different rates of virus mutations, male gender preponderance and 
ethnic origin, but it is also related to genetic polymorphism which determines the individual 
immune system reaction to measles vaccine as it happened in PNG. 
The different ethnic susceptibility to SSPE was studied in the multiethnic Israeli population. 
It was found that SSPE was more frequent among Sephardic than Ashkenazi Jews (3.4 vs. 
0.5/106, respectively) (Zilber et al., 1998). 
 
 
 
 
 
 
 
 
Fig. 5. Differences in incidence of SSPE between Israel and Gaza –West bank. Note the 
dramatic drop in the incidence in both populations (Vertical broken line).  
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Fig. 6. The increase in age of onset in Jewish Israeli patients with SSPE which followed the 
steep decline in the incidence of SSPE.  
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11. Conclusion 
SSPE can be added to the past pandemics such as small pox and poliomyelitis which were 
eradicated due to mass vaccination creating a world wide and an almost complete immunity 
to those devastating diseases. Although SSPE is not an acute infection "per se " like those 
mentioned above, this horrible disease  was also eradicated due to  mass immunization 
initiated when the "old" traditional methods of keen clinical judgment, basic epidemiology 
and the progress made by understanding the mechanisms involved in persistent viral 
infections made it clear that early infection with measles can cause SSPE. 
There is still an urgent need to lower the rate of SSPE in areas with poor measles 
immunization coverage. Although we are at present unable to offer efficient treatment and 
cure to patients with a variety of degenerative progressive neurological disorders there are 
some hints to suggest that some of them might be the result of  yet unknown "slow virus" 
infections.  
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